Koers Aradigm Corporation Nasdaq
Aandelen
US0385054004
Biotechnologie & Medisch Onderzoek
Omzet 2016 | 195K 179K | Omzet 2017 | 14,46 mln. 13,31 mln. | Marktkapitalisatie | 97,3 mln. 89,54 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -32 mln. -29,45 mln. | Nettowinst (verlies) 2017 | -10 mln. -9,2 mln. | EV/omzet 2016 | 73,3 x |
Nettoliquiditeiten 2016 | 9,37 mln. 8,62 mln. | Nettoschuld 2017 | 7,91 mln. 7,28 mln. | EV/omzet 2017 | 7,27 x |
K/w-verhouding 2016 |
-0,72
x | K/w-verhouding 2017 |
-9,3
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 60,28% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,37% | 49,46 mld. | |
+1,55% | 42,58 mld. | |
+49,11% | 42,49 mld. | |
-4,22% | 29,09 mld. | |
+11,57% | 26,61 mld. | |
-21,00% | 18,64 mld. | |
+7,36% | 13,16 mld. | |
+28,30% | 12,55 mld. | |
+23,80% | 12,1 mld. |